Debley, Jason S
- Seattle Children's Hospital · Pediatrics (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,555
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#9,555
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Debley, Jason S as a PI. Multi-PI records show the full award amount for context.
- 5R01AI163160-02R01Contact PIDysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodelingSeattle Children's Hospital · Pediatrics (investigator's affiliation)$863.9Kaward amount
- 5K24AI150991-04K24Contact PIClinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway EpitheliumSeattle Children's Hospital · Pediatrics (investigator's affiliation)$184.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Debley, Jason S as a PI.
FY2023 award administered by Seattle Children's Hospital (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardSeattle Children's Hospital
- 2009$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015R01 Grant Holder
- 2018$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #8637
- 2023$5M Cumulative Funding